CMS Drug Price Negotiation Guidance Updates with Rachel Sachs

Health Affairs' Jeff Byers welcomes
Rachel Sachs from Washington University
in St. Louis and Deputy Editor Chris
Fleming back to the pod to discuss CMS' final guidance
for the latest round of the Medicare drug price negotiation
program.


Related Articles:


Administration Releases Medicare Drug Price Negotiation
Program Final Guidance For 2028 (Health Affairs Forefront)

The Role of Combination Drugs in the Medicare Drug Price
Negotiation Program (JAMA)

Articulating policy options regarding implementation of the
Medicare drug price negotiation program’s renegotiation provision
(Brookings Institution)

Eye on The IRA (Health Affairs)